Market capitalization | $41.23m |
Enterprise Value | $-13.15m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | 0.29 |
EV/Sales (TTM) EV/Sales | -0.50 |
P/S ratio (TTM) P/S ratio | 1.58 |
P/B ratio (TTM) P/B ratio | 0.49 |
Revenue growth (TTM) Revenue growth | 27.31% |
Revenue (TTM) Revenue | $26.17m |
As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.
2 Analysts have issued a Rapid Micro Biosystems Inc - Ordinary Shares - Class A forecast:
2 Analysts have issued a Rapid Micro Biosystems Inc - Ordinary Shares - Class A forecast:
Sep '24 |
+/-
%
|
||
Revenue | 26 26 |
27%
27%
|
|
Gross Profit | -1.26 -1.26 |
84%
84%
|
|
EBITDA | -48 -48 |
16%
16%
|
EBIT (Operating Income) EBIT | -52 -52 |
16%
16%
|
Net Profit | -48 -48 |
16%
16%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Rapid Micro Biosystems, Inc. is an innovative life sciences technology company. It provides mission critical automation solutions to facilitate the efficient manufacturing and safe release of healthcare products such as biologics, vaccines, cell & gene therapies, and sterile injectable. The company was founded by Donald Straus in 2006 and is headquartered in Lowell, MA.
Head office | United States |
CEO | Robert Spignesi |
Employees | 193 |
Founded | 2006 |
Website | www.rapidmicrobio.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.